Condensed Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Revenue	$ 3,998,133
Operating expenses:
Research and development	2,005,905	$ 2,322,905
General and administrative	3,514,141	2,648,551
Total operating expenses	5,520,046	4,971,456
Loss from operations	(1,521,913)	(4,971,456)
Other income (expense), net:
Interest and other (expense) income, net	(40,163)	25,742
Foreign currency transaction gain (loss)	48,904	(2,993)
Total other income (expense), net	8,741	22,749
Net loss	$ (1,513,172)	$ (4,948,707)
Net loss per share - basic and diluted	$ (0.11)	$ (0.49)
Weighted average common shares outstanding - basic and diluted	14,139,916	10,097,107